VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Comprehensive Modeling and Discovery of Mebendazole as a Novel TRAF2- and NCK-interacting Kinase Inhibitor.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Comprehensive Modeling and Discovery of Mebendazole as a Novel TRAF2- and NCK-interacting Kinase Inhibitor.
Comprehensive Modeling and Discovery of Mebendazole as a Novel TRAF2- and NCK-interacting Kinase Inhibitor. Sci Rep. 2016 09 21; 6:33534.
View in:
PubMed
subject areas
Dasatinib
Drug Discovery
Humans
Inhibitory Concentration 50
Ligands
Mebendazole
Models, Molecular
Molecular Docking Simulation
Protein Kinase Inhibitors
Quantitative Structure-Activity Relationship
Reproducibility of Results
TNF Receptor-Associated Factor 2
authors with profiles
ZHI TAN